Iambic Therapeutics
AI-driven chemistry for medicine.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD773m (Public information from Jun 2024)
San Diego California (HQ)
Financials
Estimates*
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 2.5m | 6.6m | 7.3m |
| % growth | - | 165 % | 10 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$53.0m | Series A | ||
* | $100m | Series B | |
* | $50.0m Valuation: $500m | Series B | |
| Total Funding | AUD314m | ||
Related Content
Recent News about Iambic Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.